Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome

Introduction:Polycystic ovary syndrome (PCOS) is one of the most common endocrine abnormalities of reproductive age and has a highly heterogeneous nature regarding its multisystemic symptoms. To elicit pathophysiological roots, metabolic mapping and between-correlations among key parameters are of v...

Full description

Bibliographic Details
Main Authors:	Nil Atakul, Şahabettin Selek, Fatmanur Yılmaz Köktaşoğlu, Berna Şermin Kılıç, Ayşe Zehra Gül, Yıldız Atamer
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2022-05-01
Series:	İstanbul Medical Journal
Subjects:	polycystic ovary syndrome copper oxidative stress testosterone
Online Access:	http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/mpact-of-copper-and-oxidative-stress-ndex-levels-o/52042

Similar Items

Polycystic Ovary Induction in Mouse by Testosterone Enanthate
by: Zahra Kalhori, et al.
Published: (2013-12-01)

Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice
by: Youngjae Ryu, et al.
Published: (2021-01-01)

Correlation between Adiponectin and Free Testosterone Index and Insulin Resistance in Patients with Polycystic Ovary Syndrome
by: TANG Zixuan, LI Jing, HUANG Qi, ZHANG Ying, ZHANG Han, WANG Qian, ZHANG Lin, CHENG Yao, LIAO Xin
Published: (2023-03-01)

Effect of Hydroalcoholic Extract of Jujube Fruit (Zizyphus jujube L.) in Rats with Polycystic Ovary Syndrome
by: N Mirazi, et al.
Published: (2019-11-01)

The effect of garlic (Allium sativum) on polycystic ovary syndrome related hormones and glycemic parameters: A randomized, double-blinded clinical trial
by: Roya Zadhoush, et al.
Published: (2023-01-01)

Examination of newborn DNA methylation among women with polycystic ovary syndrome/hirsutism
by: Kristen J. Polinski, et al.
Published: (2023-12-01)

Association of Neuregulin-4 levels and body mass index with hyperandrogenism in Polycystic Ovary Syndrome patients
by: mustafa Mutashar, et al.
Published: (2024-01-01)

Violation of the Hormonal Spectrum in Polycystic Ovaries in Combination with Insulin Resistance. What is the Trigger: Insulin Resistance or Polycystic Ovary Disease?
by: Lomteva S V, et al.
Published: (2022-10-01)

Polycystic Ovary Syndrome in Adolescence
by: Rebecca Deans
Published: (2019-10-01)

Berberine in the treatment of polycystic ovary syndrome
by: Łukasz Ochyra, et al.
Published: (2022-04-01)

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
by: Ran Y, et al.
Published: (2021-03-01)

Estrogen Receptors in Polycystic Ovary Syndrome
by: Xue-Ling Xu, et al.
Published: (2021-02-01)

Testosterone and dehydroepiandrosterone sulfate serum levels and anthropometric indices among patients with polycystic ovary syndrome taking metformin and cyproterone compound
by: Mina Mohseni Shooshtari, et al.
Published: (2023-06-01)

Interplay between polycystic ovary syndrome and hypothyroidism on serum testosterone, oxidative stress and StAR gene expression in female rats
by: Sara Khodabandeh, et al.
Published: (2022-09-01)

The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome
by: Jakub Mesinovic, et al.
Published: (2020-04-01)

Mastalgia Assesment and Hormonal Correlations in Patients with Polycystic Ovary Syndrome
by: Emel Kıyak Çağlayan, et al.
Published: (2016-02-01)

Evaluation of Insulin and Estradiol in Women with Polycystic Ovary Syndrome and its Relationship With BMI
by: Hiva Danesh, et al.
Published: (2021-11-01)

Intrafollicular fibroblast growth factor 13 in polycystic ovary syndrome: relationship with androgen levels and oocyte developmental competence
by: Yu Liu, et al.
Published: (2018-09-01)

Serum under-carboxylated osteocalcin levels in women with polycystic ovary syndrome: weight-dependent relationships with endocrine and metabolic traits
by: Pepene Carmen E
Published: (2013-01-01)

Clinical Outcome and Hormone Profiles Before and After Laparoscopic Electroincision of the Ovaries in Women With Polycystic Ovary Syndrome
by: Zulfo Godinjak, et al.
Published: (2007-05-01)

Serum resistin levels, and other hormonal and biochemical parameters in patients with polycystic ovary syndrome (PCOS)
by: Kamila H. Shamam, et al.
Published: (2009-07-01)

Anxiety and Depression in Women with Polycystic Ovary Syndrome
by: Paweł Dybciak, et al.
Published: (2022-07-01)

The Relationship between Insulin Resistance and Micronutrient Intake in Polycystic Ovary Syndrome Subgroups
by: Zahra Kamali, et al.
Published: (2023-02-01)

Therapeutic Effect of Ecklonia cava Extract in Letrozole-Induced Polycystic Ovary Syndrome Rats
by: Hyun Yang, et al.
Published: (2018-11-01)

Study of Hormonal levels changes in women’s serum with polycystic ovaries syndrome (PCOS)
by: Mustafa Nuhad Jumaa, et al.
Published: (2012-06-01)

Evaluation of Thyroid Function Status in Polycystic Ovary Syndrome
by: Dr. Syeda Sobia Harmain1 , Dr. Mohd Inayatulla Khan2
Published: (2020-04-01)

Influence of Vitamin D on the Vasoactive Effect of Estradiol in a Rat Model of Polycystic Ovary Syndrome
by: Róbert Tarszabó, et al.
Published: (2021-08-01)

Multiparametric arterial spin-labeling and diffusion-weighted imaging of phenotyping of polycystic ovaries
by: Heba M. Abou El-Atta, et al.
Published: (2024-03-01)

Anthropometric Characteristics of Polycystic Ovary Syndrome and Their Associations with Insulin Resistance and Lipid Profile
by: María L. Sánchez-Ferrer, et al.
Published: (2021-06-01)

Does Oxidative Stress Cause Insulin Resistance in Women with Polycystic Ovary Syndrome?
by: Farideh Zafari-Zangeneh
Published: (2020-08-01)

Knowledge graph construction based on granulosa cells transcriptome from polycystic ovary syndrome with normoandrogen and hyperandrogen
by: Wensu Liu, et al.
Published: (2024-02-01)

Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis
by: Duaa Fahs, et al.
Published: (2023-04-01)

Polycystic Ovary Syndrome: Challenges and Possible Solutions
by: Yue Che, et al.
Published: (2023-02-01)

Changes in the microbiome in women with polycystic ovary syndrome
by: V.V. Artyomenko, et al.
Published: (2023-06-01)

Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome
by: Dongxu Wang, et al.
Published: (2023-08-01)

Antioxidative Effects of Standardized <i>Aronia melanocarpa</i> Extract on Reproductive and Metabolic Disturbances in a Rat Model of Polycystic Ovary Syndrome
by: Jovan Rudic, et al.
Published: (2022-05-01)

The efficacy of metformin and eenatide in polycystic ovary syndrome (PCOS) patients
by: Sanggeeta Kesavan, et al.
Published: (2023-06-01)

Correlation Analysis between Different Free Testosterone Index Levels and Clinical Characteristics of Patients with Polycystic Ovary Syndrome
by: FENG Xiaoling, YIN Wenqing, WANG Ying, HOU Lihui
Published: (2023-08-01)

Body Composition and Its Impact on the Hormonal Disturbances in Women with Polycystic Ovary Syndrome
by: Anna Bizoń, et al.
Published: (2021-11-01)

Investigation of the effects of astaxanthin in experimental polycystic ovary syndrome (PCOS) in rats
by: Erdem Toktay, et al.
Published: (2023-10-01)